3 assets in Periampullary Adenocarcinoma

Therapeutic assets addressing Periampullary Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
N-Butyl Cyanoacrylate Periampullary Adenocarcinoma	Minia University	P3	BB (64)
Escitalopram Periampullary Adenocarcinoma	Case Comprehensive Cancer Center	P2	CCC (53)
Glubran 2 Periampullary Adenocarcinoma	Minia University	P2	NR ()